Register entry
Novartis Pharmaceuticals Corporation
- Registered sites
- 20
- Drug products
- 210
- Live patents
- 329
- Countries
- 11
- Base
- Switzerland
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingActive ingredient (API) manufactureLabellingFinished drug manufacturePackagingparticle size reduction
Sites
Facilities
20| Site | Location | Operations | FEI |
|---|---|---|---|
| Novartis Pharmaceutical Manufacturing GmbH | KundlAustria | Analytical testing, Active ingredient (API) manufacture | 3027031635 |
| Novartis Pharmaceutical Manufacturing GmbH | LangkampfenAustria | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging | 3027031650 |
| Novartis Manufacturing NV | Puurs-Sint-AmandsBelgium | Labelling, Finished drug manufacture, Packaging | 3002037047 |
| Novartis Pharma AG | BaselSwitzerland | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3002807772 |
| Pharmanalytica SA | LocarnoSwitzerland | Analytical testing | 3002807773 |
| Novartis Pharma Schweizerhalle AG | Pratteln CHSwitzerland | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture, particle size reduction | 3002865753 |
| Novartis Pharma Stein AG | SteinSwitzerland | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging | 3002653483 |
| Novartis Pharma Produktions GmbH | WehrGermany | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3000978864 |
| NOVARTIS PHARMA SAS | HuningueFrance | Analytical testing, Active ingredient (API) manufacture | 3004864869 |
| NOVARTIS FARMA SPA | Torre AnnunziataItaly | Analytical testing, Finished drug manufacture | 3002807747 |
| Novartis Pharmaceuticals S.R.L. | Targu MuresRomania | Analytical testing, Finished drug manufacture, Packaging | 3005587283 |
| Novartis Singapore Pharmaceutical Manufacturing Pte. Ltd. | SingaporeSingapore | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3012958979 |
| Novartis d.o.o. | LjubljanaSlovenia | Analytical testing, Labelling, Finished drug manufacture, Packaging, particle size reduction | 3013358387 |
| Novartis d.o.o. | MengesSlovenia | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3002807470 |
| DSV Contract Logistics d.d. | Skofja LokaSlovenia | Analytical testing | 3027330334 |
| Novartis Saglik, Gida Ve Tarim Urunleri Sanayi Ve Ticaret Anonim Sirketi | IstanbulTurkey | Analytical testing, Finished drug manufacture | 3004121450 |
| Novartis Manufacturing LLC | Carlsbad, CAUnited States | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging | 3013510604 |
| Novartis Manufacturing LLC | Indianapolis, INUnited States | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging | 3019881323 |
| Novartis Manufacturing LLC | Indianapolis, INUnited States | Analytical testing, Active ingredient (API) manufacture | 3038913659 |
| Novartis Pharmaceuticals Corporation | Morris Plains, NJUnited States | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3010353512 |
Exclusivity
Patents
329Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| AFINITOR | EVEROLIMUS | Jul 2028 |
| ARCAPTA NEOHALER | INDACATEROL MALEATE | Oct 2028 |
| ENTRESTO | SACUBITRIL; VALSARTAN | Nov 2026 |
| ENTRESTO | SACUBITRIL; VALSARTAN | May 2027 |
| ENTRESTO | SACUBITRIL; VALSARTAN | May 2027 |
| ENTRESTO | SACUBITRIL; VALSARTAN | Nov 2027 |
| ENTRESTO | SACUBITRIL; VALSARTAN | Aug 2033 |
| ENTRESTO | SACUBITRIL; VALSARTAN | May 2036 |
| ENTRESTO SPRINKLE | SACUBITRIL; VALSARTAN | Nov 2026 |
| ENTRESTO SPRINKLE | SACUBITRIL; VALSARTAN | May 2027 |
| ENTRESTO SPRINKLE | SACUBITRIL; VALSARTAN | Feb 2037 |
| FABHALTA | IPTACOPAN HYDROCHLORIDE | Jul 2034 |
| FABHALTA | IPTACOPAN HYDROCHLORIDE | Aug 2038 |
| FABHALTA | IPTACOPAN HYDROCHLORIDE | May 2041 |
| FABHALTA | IPTACOPAN HYDROCHLORIDE | May 2041 |
| FABHALTA | IPTACOPAN HYDROCHLORIDE | Jul 2041 |
| GILENYA | FINGOLIMOD HYDROCHLORIDE | Dec 2027 |
| GILENYA | FINGOLIMOD HYDROCHLORIDE | Mar 2032 |
| GILENYA | FINGOLIMOD HYDROCHLORIDE | Sept 2032 |
| IZBA | TRAVOPROST | Mar 2029 |
| IZBA | TRAVOPROST | May 2029 |
| IZBA | TRAVOPROST | Oct 2029 |
| JADENU | DEFERASIROX | Nov 2034 |
| KISQALI | RIBOCICLIB SUCCINATE | Jun 2028 |
| KISQALI | RIBOCICLIB SUCCINATE | Dec 2028 |
| KISQALI | RIBOCICLIB SUCCINATE | Aug 2029 |
| KISQALI | RIBOCICLIB SUCCINATE | Dec 2029 |
| KISQALI | RIBOCICLIB SUCCINATE | Feb 2030 |
| KISQALI | RIBOCICLIB SUCCINATE | May 2030 |
| KISQALI | RIBOCICLIB SUCCINATE | Jun 2030 |
| KISQALI | RIBOCICLIB SUCCINATE | Nov 2030 |
| KISQALI | RIBOCICLIB SUCCINATE | Mar 2031 |
| KISQALI | RIBOCICLIB SUCCINATE | Sept 2031 |
| KISQALI | RIBOCICLIB SUCCINATE | Nov 2031 |
| KISQALI | RIBOCICLIB SUCCINATE | May 2032 |
| KISQALI | RIBOCICLIB SUCCINATE | Aug 2034 |
| KISQALI | RIBOCICLIB SUCCINATE | Feb 2035 |
| KISQALI | RIBOCICLIB SUCCINATE | Apr 2036 |
| KISQALI | RIBOCICLIB SUCCINATE | Oct 2036 |
| KISQALI FEMARA CO-PACK (COPACKAGED) | LETROZOLE; RIBOCICLIB SUCCINATE | Jun 2028 |
| KISQALI FEMARA CO-PACK (COPACKAGED) | LETROZOLE; RIBOCICLIB SUCCINATE | Dec 2028 |
| KISQALI FEMARA CO-PACK (COPACKAGED) | LETROZOLE; RIBOCICLIB SUCCINATE | Aug 2029 |
| KISQALI FEMARA CO-PACK (COPACKAGED) | LETROZOLE; RIBOCICLIB SUCCINATE | Dec 2029 |
| KISQALI FEMARA CO-PACK (COPACKAGED) | LETROZOLE; RIBOCICLIB SUCCINATE | Feb 2030 |
| KISQALI FEMARA CO-PACK (COPACKAGED) | LETROZOLE; RIBOCICLIB SUCCINATE | May 2030 |
| KISQALI FEMARA CO-PACK (COPACKAGED) | LETROZOLE; RIBOCICLIB SUCCINATE | Jun 2030 |
| KISQALI FEMARA CO-PACK (COPACKAGED) | LETROZOLE; RIBOCICLIB SUCCINATE | Nov 2030 |
| KISQALI FEMARA CO-PACK (COPACKAGED) | LETROZOLE; RIBOCICLIB SUCCINATE | Mar 2031 |
| KISQALI FEMARA CO-PACK (COPACKAGED) | LETROZOLE; RIBOCICLIB SUCCINATE | Sept 2031 |
| KISQALI FEMARA CO-PACK (COPACKAGED) | LETROZOLE; RIBOCICLIB SUCCINATE | Nov 2031 |
| KISQALI FEMARA CO-PACK (COPACKAGED) | LETROZOLE; RIBOCICLIB SUCCINATE | May 2032 |
| KISQALI FEMARA CO-PACK (COPACKAGED) | LETROZOLE; RIBOCICLIB SUCCINATE | Aug 2034 |
| KISQALI FEMARA CO-PACK (COPACKAGED) | LETROZOLE; RIBOCICLIB SUCCINATE | Feb 2035 |
| KISQALI FEMARA CO-PACK (COPACKAGED) | LETROZOLE; RIBOCICLIB SUCCINATE | Apr 2036 |
| KISQALI FEMARA CO-PACK (COPACKAGED) | LETROZOLE; RIBOCICLIB SUCCINATE | Oct 2036 |
| LEQVIO | INCLISIRAN SODIUM | May 2027 |
| LEQVIO | INCLISIRAN SODIUM | Dec 2027 |
| LEQVIO | INCLISIRAN SODIUM | Aug 2028 |
| LEQVIO | INCLISIRAN SODIUM | Dec 2028 |
| LEQVIO | INCLISIRAN SODIUM | Dec 2029 |
Catalogue
Marketed products
210Showing 150 of 210.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| ADAKVEO | crizanlizumab | INJECTION | BLA |
| Afinitor | everolimus | TABLET | NDA |
| Afinitor | everolimus | TABLET | NDA |
| Afinitor | everolimus | TABLET | NDA |
| Afinitor | everolimus | TABLET | NDA |
| Afinitor Disperz | everolimus | TABLET, FOR SUSPENSION | NDA |
| Afinitor Disperz | everolimus | TABLET, FOR SUSPENSION | NDA |
| Afinitor Disperz | everolimus | TABLET, FOR SUSPENSION | NDA |
| Arranon | nelarabine | INJECTION | NDA |
| BEOVU | brolucizumab | INJECTION, SOLUTION | BLA |
| Betoptic S | betaxolol hydrochloride | SUSPENSION/ DROPS | NDA |
| - | CANAKINUMAB | LIQUID | BULK INGREDIENT |
| COARTEM | artemether and lumefantrine | TABLET | NDA |
| COSENTYX | secukinumab | INJECTION | BLA |
| COSENTYX | secukinumab | INJECTION | BLA |
| COSENTYX | secukinumab | INJECTION | BLA |
| COSENTYX | secukinumab | INJECTION, SOLUTION, CONCENTRATE | BLA |
| - | Clarithromycin | PELLET | DRUG FOR FURTHER PROCESSING |
| Desferal | deferoxamine mesylate | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | NDA |
| Diovan | valsartan | TABLET | NDA |
| Diovan | valsartan | TABLET | NDA |
| Diovan | valsartan | TABLET | NDA |
| Diovan | valsartan | TABLET | NDA |
| Diovan | valsartan | TABLET | NDA |
| Diovan | valsartan | TABLET | NDA |
| Diovan | valsartan | TABLET | NDA |
| Diovan HCT | valsartan and hydrochlorothiazide | TABLET, FILM COATED | NDA |
| Diovan HCT | valsartan and hydrochlorothiazide | TABLET, FILM COATED | NDA |
| Diovan HCT | valsartan and hydrochlorothiazide | TABLET, FILM COATED | NDA |
| Diovan HCT | valsartan and hydrochlorothiazide | TABLET, FILM COATED | NDA |
| Diovan HCT | valsartan and hydrochlorothiazide | TABLET, FILM COATED | NDA |
| EGATEN | triclabendazole | TABLET | NDA |
| ENTRESTO | Sacubitril and Valsartan | TABLET, FILM COATED | NDA |
| ENTRESTO | Sacubitril and Valsartan | TABLET, FILM COATED | NDA |
| ENTRESTO | Sacubitril and Valsartan | TABLET, FILM COATED | NDA |
| ENTRESTO | Sacubitril and Valsartan | PELLET | NDA |
| ENTRESTO | Sacubitril and Valsartan | PELLET | NDA |
| ENTRESTO | Sacubitril and Valsartan | TABLET, FILM COATED | NDA |
| ENTRESTO | Sacubitril and Valsartan | TABLET, FILM COATED | NDA |
| Exelon | rivastigmine | PATCH, EXTENDED RELEASE | NDA |
| Exelon | rivastigmine | PATCH, EXTENDED RELEASE | NDA |
| Exelon | rivastigmine | PATCH, EXTENDED RELEASE | NDA |
| Exforge | amlodipine besylate and valsartan | TABLET, FILM COATED | NDA |
| Exforge | amlodipine besylate and valsartan | TABLET, FILM COATED | NDA |
| Exforge | amlodipine besylate and valsartan | TABLET, FILM COATED | NDA |
| Exforge | amlodipine besylate and valsartan | TABLET, FILM COATED | NDA |
| Exforge HCT | amlodipine valsartan and hydrochlorothiazide | TABLET, FILM COATED | NDA |
| Exforge HCT | amlodipine valsartan and hydrochlorothiazide | TABLET, FILM COATED | NDA |
| Exforge HCT | amlodipine valsartan and hydrochlorothiazide | TABLET, FILM COATED | NDA |
| Exforge HCT | amlodipine valsartan and hydrochlorothiazide | TABLET, FILM COATED | NDA |
| Exforge HCT | amlodipine valsartan and hydrochlorothiazide | TABLET, FILM COATED | NDA |
| Exjade | deferasirox | TABLET, FOR SUSPENSION | NDA |
| Exjade | deferasirox | TABLET, FOR SUSPENSION | NDA |
| Exjade | deferasirox | TABLET, FOR SUSPENSION | NDA |
| FABHALTA | iptacopan | CAPSULE | NDA |
| Femara | letrozole | TABLET, FILM COATED | NDA |
| Focalin XR | dexmethylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE | NDA |
| Focalin XR | dexmethylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE | NDA |
| Focalin XR | dexmethylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE | NDA |
| Focalin XR | dexmethylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE | NDA |
| Focalin XR | dexmethylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE | NDA |
| Focalin XR | dexmethylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE | NDA |
| Focalin XR | dexmethylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE | NDA |
| Focalin XR | dexmethylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE | NDA |
| Gilenya | Fingolimod hcl | CAPSULE | NDA |
| Gilenya | Fingolimod hcl | CAPSULE | NDA |
| Gleevec | imatinib mesylate | TABLET | NDA |
| Gleevec | imatinib mesylate | TABLET | NDA |
| Gleevec | imatinib mesylate | TABLET | NDA |
| HYCAMTIN | topotecan hydrochloride | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | NDA |
| ILEVRO | nepafenac | SUSPENSION/ DROPS | NDA |
| Ilaris | canakinumab | INJECTION, SOLUTION | BLA |
| Jadenu | deferasirox | TABLET, FILM COATED | NDA |
| Jadenu | deferasirox | TABLET, FILM COATED | NDA |
| Jadenu | deferasirox | TABLET, FILM COATED | NDA |
| Jadenu | deferasirox | GRANULE | NDA |
| Jadenu | deferasirox | GRANULE | NDA |
| Jadenu | deferasirox | GRANULE | NDA |
| KESIMPTA | ofatumumab | INJECTION, SOLUTION | BLA |
| KISQALI | ribociclib | TABLET, FILM COATED | NDA |
| KISQALI | ribociclib | TABLET, FILM COATED | NDA |
| KISQALI | ribociclib | TABLET, FILM COATED | NDA |
| KISQALI FEMARA CO-PACK | letrozole and ribociclib | KIT | NDA |
| KISQALI FEMARA CO-PACK | letrozole and ribociclib | KIT | NDA |
| KISQALI FEMARA CO-PACK | letrozole and ribociclib | KIT | NDA |
| KYMRIAH | tisagenlecleucel | INJECTION, SUSPENSION | BLA |
| KYMRIAH | tisagenlecleucel | INJECTION, SUSPENSION | BLA |
| LEQVIO | inclisiran | INJECTION, SOLUTION | NDA |
| LOCAMETZ | kit for the preparation of gallium Ga 68 gozetotide | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | NDA |
| Lamprene | Clofazimine | CAPSULE, LIQUID FILLED | NDA |
| Lotrel | amlodipine besylate and benazepril hydrochloride | CAPSULE | NDA |
| Lotrel | amlodipine besylate and benazepril hydrochloride | CAPSULE | NDA |
| Lotrel | amlodipine besylate and benazepril hydrochloride | CAPSULE | NDA |
| Lotrel | amlodipine besylate and benazepril hydrochloride | CAPSULE | NDA |
| MAXITROL | neomycin sulfate, polymyxin b sulfate and dexamethasone | OINTMENT | NDA |
| MAYZENT | siponimod | TABLET, FILM COATED | NDA |
| MAYZENT | siponimod | TABLET, FILM COATED | NDA |
| MAYZENT | siponimod | TABLET, FILM COATED | NDA |
| Mekinist | trametinib | TABLET, FILM COATED | NDA |
| Mekinist | trametinib | TABLET, FILM COATED | NDA |
| Mekinist | trametinib | POWDER, FOR SOLUTION | NDA |
| Myfortic | mycophenolic acid | TABLET, DELAYED RELEASE | NDA |
| Myfortic | mycophenolic acid | TABLET, DELAYED RELEASE | NDA |
| Neoral | cyclosporine | CAPSULE, LIQUID FILLED | NDA |
| Neoral | cyclosporine | CAPSULE, LIQUID FILLED | NDA |
| Neoral | cyclosporine | SOLUTION | NDA |
| PIQRAY | alpelisib | TABLET | NDA |
| PIQRAY | alpelisib | TABLET | NDA |
| PIQRAY | alpelisib | KIT | NDA |
| PLUVICTO | lutetium Lu 177 vipivotide tetraxetan | INJECTION, SOLUTION | NDA |
| PROMACTA | eltrombopag olamine | TABLET, FILM COATED | NDA |
| PROMACTA | eltrombopag olamine | TABLET, FILM COATED | NDA |
| PROMACTA | eltrombopag olamine | TABLET, FILM COATED | NDA |
| PROMACTA | eltrombopag olamine | TABLET, FILM COATED | NDA |
| PROMACTA | eltrombopag olamine | POWDER, FOR SUSPENSION | NDA |
| PROMACTA | eltrombopag olamine | POWDER, FOR SUSPENSION | NDA |
| RHAPSIDO | remibrutinib | TABLET | NDA |
| RYDAPT | RYDAPT | CAPSULE, LIQUID FILLED | NDA |
| Ritalin | methylphenidate hydrochloride | TABLET | NDA |
| Ritalin | methylphenidate hydrochloride | TABLET | NDA |
| Ritalin | methylphenidate hydrochloride | TABLET | NDA |
| Ritalin LA | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE | NDA |
| Ritalin LA | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE | NDA |
| Ritalin LA | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE | NDA |
| Ritalin LA | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE | NDA |
| SCEMBLIX | asciminib | TABLET, FILM COATED | NDA |
| SCEMBLIX | asciminib | TABLET, FILM COATED | NDA |
| SCEMBLIX | asciminib | TABLET, FILM COATED | NDA |
| - | SECUKINUMAB | LIQUID | BULK INGREDIENT |
| Sandimmune | cyclosporine | INJECTION | NDA |
| Sandimmune | cyclosporine | CAPSULE, LIQUID FILLED | NDA |
| Sandimmune | cyclosporine | CAPSULE, LIQUID FILLED | NDA |
| Sandostatin | octreotide acetate | INJECTION, SOLUTION | NDA |
| Sandostatin | octreotide acetate | INJECTION, SOLUTION | NDA |
| Sandostatin | octreotide acetate | INJECTION, SOLUTION | NDA |
| Sandostatin LAR Depot | octreotide acetate | KIT | NDA |
| Sandostatin LAR Depot | octreotide acetate | KIT | NDA |
| Sandostatin LAR Depot | octreotide acetate | KIT | NDA |
| Simulect | basiliximab | INJECTION, POWDER, FOR SOLUTION | BLA |
| Simulect | basiliximab | INJECTION, POWDER, FOR SOLUTION | BLA |
| - | Somatropin | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| TABRECTA | capmatinib | TABLET, FILM COATED | NDA |
| TABRECTA | capmatinib | TABLET, FILM COATED | NDA |
| TOBREX | tobramycin | OINTMENT | NDA |
| TRIESENCE | triamcinolone acetonide | INJECTION, SUSPENSION | NDA |
| TYKERB | lapatinib | TABLET | NDA |
| Tafinlar | dabrafenib | CAPSULE | NDA |
| Tafinlar | dabrafenib | CAPSULE | NDA |
| Tafinlar | dabrafenib | TABLET, FOR SUSPENSION | NDA |
| Tasigna | nilotinib | CAPSULE | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.